MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:MDXXF)

0.1616 UNCHANGED
Streaming Delayed Price Updated: 2:18 PM EDT, Aug 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 0.1616
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1616
Today's Range 0.1616 - 0.1616
52wk Range 0.0614 - 0.2000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
From PharmAla Biotech
Via GlobeNewswire

Performance

YTD
+84.1%
+84.1%
1 Month
+54.5%
+54.5%
3 Month
+39.2%
+39.2%
6 Month
+102.0%
+102.0%
1 Year
+72.8%
+72.8%

More News

Read More
News headline image
PharmAla Biotech Executes Definitive Agreement to Form Special Purpose Vehicle, Restora Neurosciences, for Clinical Development of Patented Novel MDXX Molecule APA-01
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order
From PharmAla Biotech
Via GlobeNewswire
News headline image
Cortexa Advances Commercialisation of MDMA Supply in Australia
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla To Supply Østfold Hospital Trust with LaNeo™ MDMA for Clinical Research
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Completes Shipment of LaNeo™ MDMA to Johns Hopkins
From PharmAla Biotech
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update
From PharmAla Biotech
Via GlobeNewswire
News headline image
Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
PharmAla Contracts with Partner to Act as US Distributor
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Signs Advisory Agreement with Mr. Matthew Azrieli
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla To Supply Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License, in Partnership with MAPS Israel
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial ↗
Via Benzinga
News headline image
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial ↗
Via Benzinga
News headline image
PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial ↗
Via Benzinga
News headline image
PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract ↗
Via Benzinga
News headline image
PharmAla Launches MDMA Clinical Trial Tool for Researchers
From PharmAla Biotech
Via GlobeNewswire
News headline image
PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002
From PharmAla Biotech
Via GlobeNewswire
News headline image
Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale ↗
Via Benzinga
News headline image
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More ↗
Via Benzinga

Frequently Asked Questions

Is MDXXF publicly traded?
Yes, MDXXF is publicly traded.
What exchange does MDXXF trade on?
MDXXF trades on the OTC Traded
What is the ticker symbol for MDXXF?
The ticker symbol for MDXXF is MDXXF on the OTC Traded
What is the current price of MDXXF?
The current price of MDXXF is 0.1616
When was MDXXF last traded?
The last trade of MDXXF was at 08/31/26 02:18 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story